| Year |
Citation |
Score |
| 2020 |
Lee SJ, Lehar A, Meir JU, Koch C, Morgan A, Warren LE, Rydzik R, Youngstrom DW, Chandok H, George J, Gogain J, Michaud M, Stoklasek TA, Liu Y, Germain-Lee EL. Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight. Proceedings of the National Academy of Sciences of the United States of America. PMID 32900939 DOI: 10.1073/Pnas.2014716117 |
0.373 |
|
| 2020 |
Suh J, Kim NK, Lee SH, Eom JH, Lee Y, Park JC, Woo KM, Baek JH, Kim JE, Ryoo HM, Lee SJ, Lee YS. GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone. Proceedings of the National Academy of Sciences of the United States of America. PMID 32071240 DOI: 10.1073/Pnas.1916034117 |
0.389 |
|
| 2019 |
Suh J, Eom JH, Kim NK, Woo KM, Baek JH, Ryoo HM, Lee SJ, Lee YS. Growth differentiation factor 11 locally controls anterior-posterior patterning of the axial skeleton. Journal of Cellular Physiology. PMID 31183862 DOI: 10.1002/Jcp.28904 |
0.336 |
|
| 2019 |
Goh Q, Song T, Petrany MJ, Cramer AA, Sun C, Sadayappan S, Lee SJ, Millay DP. Myonuclear accretion is a determinant of exercise-induced remodeling in skeletal muscle. Elife. 8. PMID 31012848 DOI: 10.7554/Elife.44876 |
0.323 |
|
| 2015 |
Lee YS, Lee SJ. Roles of GASP-1 and GDF-11 in Dental and Craniofacial Development. Journal of Oral Medicine and Pain. 40: 110-114. PMID 26942165 DOI: 10.14476/Jomp.2015.40.3.110 |
0.357 |
|
| 2015 |
DiGirolamo DJ, Singhal V, Chang X, Lee SJ, Germain-Lee EL. Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta. Bone Research. 3: 14042. PMID 26161291 DOI: 10.1038/Boneres.2014.42 |
0.356 |
|
| 2014 |
Mielcarek M, Rattray I, Osborne G, Jolinon N, Dick J, Bondulich M, Franklin S, Ahmed M, Benjamin A, Goodwin D, Lazell H, Chang X, Lehar A, Wood T, Munoz-Sanjuan I, ... ... Lee S, et al. M09 Myostatin Inhibition as a Novel Approach to Targeting Muscle Pathology in HD Journal of Neurology, Neurosurgery & Psychiatry. 85: A97-A97. DOI: 10.1136/Jnnp-2014-309032.281 |
0.364 |
|
| 2010 |
Lee SJ. Extracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry. 10: 183-194. PMID 21423813 DOI: 10.2174/187152210793663748 |
0.371 |
|
| 2010 |
Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, Cohn RD, Barton ER. Regulation of muscle mass by follistatin and activins. Molecular Endocrinology (Baltimore, Md.). 24: 1998-2008. PMID 20810712 DOI: 10.1210/me.2010-0127 |
0.376 |
|
| 2007 |
Lee SJ. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. Plos One. 2: e789. PMID 17726519 DOI: 10.1371/journal.pone.0000789 |
0.302 |
|
| 2001 |
Lee S, McPherron AC. Regulation of myostatin activity and muscle growth Proceedings of the National Academy of Sciences of the United States of America. 98: 9306-9311. PMID 11459935 DOI: 10.1073/Pnas.151270098 |
0.407 |
|
| 1987 |
Lee SJ, Nathans D. Secretion of proliferin. Endocrinology. 120: 208-13. PMID 3780559 DOI: 10.1210/Endo-120-1-208 |
0.527 |
|
| 1985 |
Linzer DI, Lee SJ, Ogren L, Talamantes F, Nathans D. Identification of proliferin mRNA and protein in mouse placenta. Proceedings of the National Academy of Sciences of the United States of America. 82: 4356-9. PMID 3859868 DOI: 10.1073/Pnas.82.13.4356 |
0.52 |
|
| Show low-probability matches. |